Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
1(14%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
1
14%
Ph not_applicable
1
14%
Ph phase_3
1
14%
Ph phase_4
2
29%

Phase Distribution

1

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 3Large-scale testing
1(20.0%)
Phase 4Post-market surveillance
2(40.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

6 of 6 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(6)

Detailed Status

Completed6
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (20.0%)
Phase 31 (20.0%)
Phase 42 (40.0%)
N/A1 (20.0%)

Trials by Status

recruiting114%
completed686%

Recent Activity

1 active trials
Showing 5 of 7
recruitingnot_applicable

Influenza Immunization in Adults Over Age 75

NCT02200276
completedearly_phase_1

Non-specific Effects of FLU-MMR Vaccines in Adults

NCT05401448
completed

Adjuvanted Influenza Vaccination Year 2 Follow-On Survey

NCT03599739
completed

Transmission of Influenza Virus From Asymptomatic Healthcare Workers and Inpatients in the Acute Care Hospital Setting

NCT02478905
completedphase_3

Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines

NCT00197288
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT02200276Not Applicable

Influenza Immunization in Adults Over Age 75

Recruiting
NCT05401448Early Phase 1

Non-specific Effects of FLU-MMR Vaccines in Adults

Completed
NCT03599739

Adjuvanted Influenza Vaccination Year 2 Follow-On Survey

Completed
NCT02478905

Transmission of Influenza Virus From Asymptomatic Healthcare Workers and Inpatients in the Acute Care Hospital Setting

Completed
NCT00197288Phase 3

Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines

Completed
NCT00311428Phase 4

Safety and Immunogenicity of Three Commercially Available Influenza Vaccines in Children Aged 6 to <36 Months

Completed
NCT00329251Phase 4

Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIV

Completed

All 7 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
7